An antiemetic and NK1 antagonist (Ki 3 nM IC50 0.09 nM for the human receptor) selective for NK1 over NK3 receptors (Ki 454.1 nM for human NK3) prevents substance P-induced plasma extravasation into the esophagus of guinea pigs at 1 mg/kg reduces NK1-agonist-induced foot tapping in gerbils